div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=-20151209-se-indicacin-de-radioterapia-y-respnesta-el-s6vofucron-porhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: 20151209 · se indicación de radioterapia y respneSta El S6Vofucron por 70 por y por T 3 clinico Obruvimos 29% de PSA nadir nghnl: 696% parcial y sin 58% de recurrencia loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentscoreader034viewer20220503125f73f55770b19858fe098da1html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=-20151209-se-indicacin-de-radioterapia-y-respnesta-el-s6vofucron-porhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: 20151209 · se indicación de radioterapia y respneSta El S6Vofucron por 70 por y por T 3 clinico Obruvimos 29% de PSA nadir nghnl: 696% parcial y sin 58% de recurrencia loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentscoreader034viewer20220503125f73f55770b19858fe098da1html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=-20151209-se-indicacin-de-radioterapia-y-respnesta-el-s6vofucron-porhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: 20151209 · se indicación de radioterapia y respneSta El S6Vofucron por 70 por y por T 3 clinico Obruvimos 29% de PSA nadir nghnl: 696% parcial y sin 58% de recurrencia loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentscoreader034viewer20220503125f73f55770b19858fe098da1html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=-20151209-se-indicacin-de-radioterapia-y-respnesta-el-s6vofucron-porhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: 20151209 · se indicación de radioterapia y respneSta El S6Vofucron por 70 por y por T 3 clinico Obruvimos 29% de PSA nadir nghnl: 696% parcial y sin 58% de recurrencia loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentscoreader034viewer20220503125f73f55770b19858fe098da1html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=-20151209-se-indicacin-de-radioterapia-y-respnesta-el-s6vofucron-porhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: 20151209 · se indicación de radioterapia y respneSta El S6Vofucron por 70 por y por T 3 clinico Obruvimos 29% de PSA nadir nghnl: 696% parcial y sin 58% de recurrencia loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentscoreader034viewer20220503125f73f55770b19858fe098da1html5thumbnails5jpg width=140 height=200 divdiv
